» Articles » PMID: 22931630

The Added-up Albumin Enhances the Diuretic Effect of Furosemide in Patients with Hypoalbuminemic Chronic Kidney Disease: a Randomized Controlled Study

Overview
Journal BMC Nephrol
Publisher Biomed Central
Specialty Nephrology
Date 2012 Aug 31
PMID 22931630
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic kidney disease (CKD) with edema is a common clinical problem resulting from defects in water and solute excretion. Furosemide is the drug of choice for treatment. In theory, good perfusion and albumin are required for the furosemide to be secreted at the tubular lumen. Thus, in the situation of low glomerular filtration rate (GFR) and hypoalbuminemia, the efficacy of furosemide alone might be limited. There has been no study to validate the effectiveness of the combination of furosemide and albumin in this condition.

Methods: We conducted a randomized controlled crossover study to compare the efficacy of diuretics between furosemide alone and the combination of furosemide plus albumin in stable hypoalbuminemic CKD patients by measuring urine output and sodium. The baseline urine output/sodium at 6 and 24 hours were recorded. The increment of urine output/sodium after treatment at 6 and 24 hours were calculated by using post-treatment minus baseline urine output/sodium at the corresponding period.

Results: Twenty-four CKD patients (GFR = 31.0 ± 13.8 mL/min) with hypoalbuminemia (2.98 ± 0.30 g/dL) were enrolled. At 6 hours, there were significant differences in the increment of urine volume (0.47 ± 0.40 vs 0.67 ± 0.31 L, P < 0.02) and urine sodium (37.5 ± 29.3 vs 55.0 ± 26.7 mEq, P < 0.01) between treatment with furosemide alone and with furosemide plus albumin. However, at 24 hours, there were no significant differences in the increment of urine volume (0.49 ± 0.47 vs 0.59 ± 0.50 L, P = 0.46) and urine sodium (65.3 ± 47.5 vs 76.1 ± 50.1 mEq, P = 0.32) between the two groups.

Conclusion: The combination of furosemide and albumin has a superior short-term efficacy over furosemide alone in enhancing water and sodium diuresis in hypoalbuminemic CKD patients.

Trial Registration: The Australian New Zealand Clinical Trials Registration (ANZCTR12611000480987).

Citing Articles

Albumin-Mediated Drug Uptake by Organic Anion Transporter 1/3 Is Real: Implications for the Prediction of Active Renal Secretion Clearance.

Tan S, Tillmann A, Murby S, Rostami-Hodjegan A, Scotcher D, Galetin A Mol Pharm. 2024; 21(9):4603-4617.

PMID: 39166754 PMC: 11372837. DOI: 10.1021/acs.molpharmaceut.4c00504.


Hypoalbuminaemia and heart failure: A practical review of current evidence.

Biancucci M, Barbiero R, Pennella B, Cannata A, Ageno W, Tangianu F Eur J Heart Fail. 2024; 27(2):293-306.

PMID: 38962822 PMC: 11860734. DOI: 10.1002/ejhf.3363.


Diuretic resistance and the role of albumin in congestive heart failure.

Fernandez Hazim C, Duarte G, Urena A, Jain S, Mishra R, Vittorio T Drugs Context. 2024; 12.

PMID: 38188263 PMC: 10768781. DOI: 10.7573/dic.2023-6-5.


PoCUS in nephrology: a new tool to improve our diagnostic skills.

Romero-Gonzalez G, Manrique J, Slon-Roblero M, Husain-Syed F, de la Espriella R, Ferrari F Clin Kidney J. 2023; 16(2):218-229.

PMID: 36755847 PMC: 9900589. DOI: 10.1093/ckj/sfac203.


Impact of Albumin Binding Function on Pharmacokinetics and Pharmacodynamics of Furosemide.

Klinkmann G, Klammt S, Jaschke M, Henschel J, Gloger M, Reuter D Medicina (Kaunas). 2022; 58(12).

PMID: 36556982 PMC: 9787406. DOI: 10.3390/medicina58121780.


References
1.
Vargo D, Kramer W, Black P, Smith W, Serpas T, Brater D . Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther. 1995; 57(6):601-9. DOI: 10.1016/0009-9236(95)90222-8. View

2.
Kirchner K, Voelker J, Brater D . Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome. J Pharmacol Exp Ther. 1990; 252(3):1097-101. View

3.
Ellison D . Diuretic drugs and the treatment of edema: from clinic to bench and back again. Am J Kidney Dis. 1994; 23(5):623-43. DOI: 10.1016/s0272-6386(12)70272-x. View

4.
Chennavasin P, Seiwell R, Brater D, Liang W . Pharmacodynamic analysis of the furosemide-probenecid interaction in man. Kidney Int. 1979; 16(2):187-95. DOI: 10.1038/ki.1979.120. View

5.
Hropot M, Fowler N, Karlmark B, Giebisch G . Tubular action of diuretics: distal effects on electrolyte transport and acidification. Kidney Int. 1985; 28(3):477-89. DOI: 10.1038/ki.1985.154. View